Takeda

VPRIV

Manufacturer:

Takeda

Vpriv HCPCS:

J3385

HCPCS Code Descriptor:

Injection, velaglucerase alfa, 100 units

Category:

J Code

Vpriv NDCs:

54092-0701-04

Primary Type:

Enzyme Replacement Therapy

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vpriv:

VPRIV is an Enzyme Replacement Therapy drug manufactured by Takeda and administered via the Intravenous route of administration. The J Code: J3385 is aligned to the drug VPRIV.

ACCESS PRICING AND MORE BY REGISTERING

J3385 Added Date:

January 1, 2011

J3385 Effective Date:

January 1, 2011

J3385 Termination Date:

HCPCS Active

Vpriv billing and coding information can be found through Takeda at the link below:
Vpriv patient assistance information can be found through Takeda OnePath at the URL: https://www.vpriv.com/support-programs
VPRIV prescribing information can be found at the link below:
Information regarding VPRIV’s side effects can be found at MedlinePlus